Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-22

FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)

View source ↗

Summary

FDA approved a supplemental application for amlodipine besylate and benazepril hydrochloride, authorizing a fixed-dose combination product for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine Besylate and Benazepril Hydrochloride (Amlodipine besylate and benazepril hydrochloride)

Snippet

SUPPL AP for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE (AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE)